Why the study?
A multimodal imaging approach to cardiac paragangliomas is not yet standardized, prompting an investigation into the roles of CCT, CMR, PET, and SPECT in diagnosis, characterization, and monitoring.
What is the role of advanced diagnostic imaging (CCT, CMR, PET, SPECT) in the diagnosis, characterization, and monitoring of cardiac paragangliomas?
Population
Patients with cardiac paragangliomas
Design
Systematic review
Key result
A multimodal imaging approach combining CCT, CMR, PET, and SPECT locates and functionally characterizes cardiac paragangliomas, aiding in diagnosis, monitoring, and treatment planning.
Authors
Loading...
Supports multimodal imaging for cardiac paraganglioma diagnosis and monitoring; extends synthesized evidence for rare tumors.
Systematic Review
What is the role of advanced diagnostic imaging (CCT, CMR, PET, SPECT) in the diagnosis, characterization, and monitoring of cardiac paragangliomas?
A multimodal imaging approach combining CCT, CMR, PET, and SPECT is useful for the diagnosis, characterization, and monitoring of rare cardiac paragangliomas.
Punzo et al. (2024) conducted a systematic review in Cardiac Paraganglioma. Advanced diagnostic imaging (CCT, CMR, PET, SPECT) was evaluated on Diagnosis, characterization, and monitoring of cardiac PGLs. A multimodal imaging approach combining CCT, CMR, PET, and SPECT locates and functionally characterizes cardiac paragangliomas, aiding in diagnosis, monitoring, and treatment planning.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: